Video

Dr. Bianchi on Diagnostic Factors for AL Amyloidosis

Giada Bianchi, MD, discusses diagnostic factors for light chain amyloidosis.

Giada Bianchi, MD, a physician at Dana-Farber Cancer Institute, and an instructor in medicine at Harvard Medical School, discusses diagnostic factors for light chain (AL) amyloidosis.

Diagnostic delay remains as a notable challenge in AL amyloidosis, according to Bianchi. Patients who have advanced cardiac involvement often express disease symptoms for months and possibly years, Bianchi explains. Notably, this disease is a mimicker and can present with subtle symptoms at the outset, which can make the diagnostic process challenging, she says.

Depending on the organ that is involved, patients can present with a variety of symptoms. ​​​​​​​As such, it is important to be aware that any patient who has progressive symptoms of unclear nature, particularly those with smoldering myeloma, should be screened for AL amyloidosis, Bianchi concludes.

Related Videos
Nancy U. Lin, MD, discusses the safety data from DESTINY-Breast12 with T-DXd for HER2+ advanced/metastatic breast cancer with or without brain metastases.
Daniel DeAngelo, MD, PhD, discusses how the shift away from chemotherapy has affected the management of chronic lymphocytic leukemia.
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS
Meletios (Thanos) Dimopoulos, MD, professor, therapeutics, Hematology Oncology, National and Kapodistrian University of Athens School of Medicine
Michel Delforge, MD, PhD
Ashraf Z. Badros, MBCHB, professor, medicine, Medical Oncology, Hematology Oncology, University of Maryland Medical System
Binod Dhakal, MD
Michel Delforge, MD, PhD, professor, Faculty of Medicine, Department of Hematology, director, member, Leuven Cancer Institute, member, Senior Academic Staff, Council of the Faculty of Medicine, Council of the Department of Oncology, University Hospital Leuven, University of Leuven
Ajay K. Nooka, MD, MPH, FACP